Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02010112 · ClinicalTrials.gov registry record · Phase 3
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
A Phase 3 study, sponsored by Meridian Bioscience.
- Completed
- Registry status
- Phase 3
- Development phase
- 193
- Enrollment target
NCT02010112 is a Phase 3 study that has completed, run by Meridian Bioscience. The registered enrollment target is 193 participants.
The verdict
NCT02010112, a Phase 3 study, has completed, sponsored by Meridian Bioscience.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 193 participants
- Enrollment target
Study Summary
A new method of breath collection for testing for Helicobacter Pylori infection has been developed by Exalenz. In this study, it will be compared to the gold standard- endoscopy results to prove its accuracy.
Interventions
- OTHER Breath Test Collection bags
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02010112
The ClinicalTrials.gov registry entry for NCT02010112 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Meridian Bioscience, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breath Test Collection bags is the first listed.
NCT02010112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02010112 about?
NCT02010112 is a clinical study titled "Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori". A new method of breath collection for testing for Helicobacter Pylori infection has been developed by Exalenz. In this study, it will be compared to the gold standard- endoscopy results to prove its accuracy.
What is the current status of trial NCT02010112?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 193 participants. The study started on 2014-01. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02010112?
The interventions under investigation include: Breath Test Collection bags (OTHER).
Who is sponsoring clinical trial NCT02010112?
This trial is sponsored by Meridian Bioscience, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.